Atlas Trials

Campath-1H + FK506 and Methylprednisolone for GVHD

Clinical trial NCT00109993 · COMPLETED

Trial details

NCT number
NCT00109993
Sponsor
Case Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesNeuroblastomaOvarian CancerTesticular Germ Cell Tumor
Start date
2005-01-01
Primary completion
2006-06-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.